Stocks-BMRN-BioMarin Pharmaceutical Inc

BMRN BioMarin Pharmaceutical Inc

89.80 0 (0%)
Market ClosedDelayed Prices By NASDAQ, in USD
Trade
Trade

FINANCIAL SUMMARY

For the fiscal year ended 31/12/2022: BioMarin Pharmaceutical Inc's revenues increased by 13.53% and amounted to 2.10B. Net income increased by 320.91% to 141.56M. Net assets decreased by NaN to 4.60B and EPS decreased from N/A to 0.75.
BMRN's Investor Relations
Income StatementBalance SheetCash Flow Statement
Quarterly
Gross Margin
75.13%
Net Profit Margin
12.16%
Operating Margin
4.93%
Return On Investment
4.27%